169 related articles for article (PubMed ID: 2885739)
21. Density of alpha-2A adrenoceptors and Gi proteins in the human brain: ratio of high-affinity agonist sites to antagonist sites and effect of age.
Sastre M; García-Sevilla JA
J Pharmacol Exp Ther; 1994 Jun; 269(3):1062-72. PubMed ID: 7912275
[TBL] [Abstract][Full Text] [Related]
22. Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations.
Schloos J; Wellstein A; Palm D
Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):48-59. PubMed ID: 2888026
[TBL] [Abstract][Full Text] [Related]
23. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens.
Minneman KP; Abel PW
Mol Pharmacol; 1984 Jan; 25(1):56-63. PubMed ID: 6143249
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
Boyajian CL; Leslie FM
J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
[TBL] [Abstract][Full Text] [Related]
25. Alpha 2A adrenoceptors and non-adrenergic idazoxan binding sites in calf brain and retina are distinct from those in human brain.
Van Liefde I; Vauquelin G; De Keyser J; De Backer JP; De Vos H
Neurochem Int; 1993 May; 22(5):501-9. PubMed ID: 8387366
[TBL] [Abstract][Full Text] [Related]
26. [3H]idazoxan binding to the ovine myometrium. Binding characteristics and changes due to steroid hormones.
Vass-Lopez A; Garcia-Villar R; Lafontan M; Toutain PL
J Pharmacol Exp Ther; 1990 May; 253(2):819-24. PubMed ID: 1971023
[TBL] [Abstract][Full Text] [Related]
27. Comparison of agonist-induced changes in beta- and alpha 1-adrenergic receptors of DDT1 MF-2 cells.
Toews ML
Mol Pharmacol; 1987 Jan; 31(1):58-68. PubMed ID: 2880284
[TBL] [Abstract][Full Text] [Related]
28. The relationship between alpha 1-adrenergic receptor occupancy and response in BC3H-1 muscle cells.
Brown RD; Berger KD; Taylor P
Mol Pharmacol; 1987 Jul; 32(1):43-52. PubMed ID: 2885737
[TBL] [Abstract][Full Text] [Related]
29. Phorbol ester and staurosporine modulation of antagonist and agonist binding to alpha-2 adrenergic receptors: differential influence on Na+ versus guanylylnucleotide regulation.
Jagadeesh G; Deth RC
J Pharmacol Exp Ther; 1992 Aug; 262(2):775-83. PubMed ID: 1323662
[TBL] [Abstract][Full Text] [Related]
30. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
De Léan A; Ong H; Gutkowska J; Schiller PW; McNicoll N
Mol Pharmacol; 1984 Nov; 26(3):498-508. PubMed ID: 6092899
[TBL] [Abstract][Full Text] [Related]
31. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
Lenox RH; Ellis J; Van Riper D; Ehrlich YH
Mol Pharmacol; 1985 Jan; 27(1):1-9. PubMed ID: 2981397
[TBL] [Abstract][Full Text] [Related]
32. High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes.
Convents A; Convents D; De Backer JP; De Keyser J; Vauquelin G
Biochem Pharmacol; 1989 Feb; 38(3):455-63. PubMed ID: 2563652
[TBL] [Abstract][Full Text] [Related]
33. Selective blockade and recovery of cell surface alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells. Studies with the irreversible antagonist benextramine.
McKernan RM; Strickland WR; Insel PA
Mol Pharmacol; 1988 Jan; 33(1):51-7. PubMed ID: 2826999
[TBL] [Abstract][Full Text] [Related]
34. Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors.
U'Prichard DC; Greenberg DA; Snyder SH
Mol Pharmacol; 1977 May; 13(3):454-73. PubMed ID: 17827
[No Abstract] [Full Text] [Related]
35. Phorbol ester-induced modulation of agonist binding to alpha-1 adrenergic receptors in bovine aortic membranes.
Jagadeesh G; Deth RC
J Pharmacol Exp Ther; 1988 Oct; 247(1):196-202. PubMed ID: 2902212
[TBL] [Abstract][Full Text] [Related]
36. Alpha-2 adrenoreceptors on arterial smooth muscle: selective labeling by [3H]clonidine.
Weiss RJ; Webb RC; Smith CB
J Pharmacol Exp Ther; 1983 Jun; 225(3):599-605. PubMed ID: 6134815
[TBL] [Abstract][Full Text] [Related]
37. Non-adrenergic sites for imidazolines are not directly involved in the alpha 2-adrenergic antilipolytic effect of UK 14304 in rat adipocytes.
Carpéné C; Galitzky J; Larrouy D; Langin D; Lafontan M
Biochem Pharmacol; 1990 Aug; 40(3):437-45. PubMed ID: 1974423
[TBL] [Abstract][Full Text] [Related]
38. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
Hoyer D; Reynolds EE; Molinoff PB
Mol Pharmacol; 1984 Mar; 25(2):209-18. PubMed ID: 6142414
[TBL] [Abstract][Full Text] [Related]
39. Alpha 1 and alpha 2 Adrenergic receptors in mouse brain astrocytes from primary cultures.
Ebersolt C; Perez M; Bockaert J
J Neurosci Res; 1981; 6(5):643-52. PubMed ID: 6119369
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor.
Lanier SM; Hess HJ; Grodski A; Graham RM; Homcy CJ
Mol Pharmacol; 1986 Mar; 29(3):219-27. PubMed ID: 3005829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
